The tweet was deleted by the author.
But we saved everything 🙂.
Becton Dickinson announced that its BD CentroVena One has earned a Vizient Innovative Technology contract.
The company said the technology was recognized for its potential to simplify central line insertion and improve care delivery. Further information is available on Becton Dickinson's website.
View post on X Loading...
BDX is trading at $144.32, which is below the SMA-20 at $146.73, SMA-50 at $148.67, and SMA-200 at $146.02, indicating continued pressure from sellers across short-, medium-, and long-term timeframes. The Ichimoku Kijun at $146.66 stands above the current price, serving as immediate resistance; near-term support sits at the SMA-200 ($146.02) and HMA ($141.30), while resistance is seen at the Kijun ($146.66) and SMA-50 ($148.67).
Momentum remains soft, as both MACD (D1: -2.05) and ADX (D1: 15.21) signal a lack of strong trend direction, while oscillators such as RSI (D1: 38.03), Stoch RSI (D1: 2.82), and CCI (D1: -183.10) all highlight oversold conditions, suggesting near-term downside exhaustion. BBP (D1: -2.35, oversold) confirms that sellers dominate recent trading. Weekly, BDX is trading at $144.32, up from the previous week’s close of $143.98, reflecting a marginal 0.25% gain with volatility standing at 3.92%. Price remains in the upper part of the weekly range, indicating a modest recovery from the weekly low but still limited upside follow-through. In today’s session, the stock is up 2.57% and continues to rebound from oversold territory, yet medium-term indicators do not confirm a sustained bullish shift.
Looking ahead, the anticipated trading range for BDX next week is $142.50–$146.50, bracketing current levels and falling well within the yearly bounds between the 52-week low ($100.31) and high ($187.35). Given only one W1 indicator (MA-100-SMA) signaling "Buy" while others remain on "Sell" or "Neutral", the probability of a meaningful move higher is very low (less than 20%), making a renewed decline more likely in the short term. The baseline scenario is sideways trading within the $142.50–$146.50 corridor. A bullish scenario would require a breakout above $146.66 (Kijun), aiming toward $148.67 (SMA-50), while a bearish break below $142.50 could accelerate downside toward the next key support.
Previously it was reported that Becton Dickinson was experiencing persistent selling pressure, with analysts highlighting a cautious outlook and limited upward momentum. In the current context, investors should closely monitor for a potential shift in trend, with the prevailing scenario suggesting that sustained movement above current resistance could signal the early stages of a recovery.